Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing surveillance of INAVIR (laninamivir) in children under 5 years with influenza
jRCT1080224937Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of laninamivir octanoate in Influenza A infection and influenza B, sponsored by Daiichi Sankyo Co., Ltd. Started Nov 2019; status: completed.
02
Drugs
laninamivir octanoate
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on jRCT1080224937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224937.